LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) show limited efficacy in hepatocellular carcinoma (HCC) owing to an immunosuppressive tumor microenvironment (TME). Although ubiquitin-specific peptidase 39 (USP39) promotes tumor progression, its role in mediating ICI resistance remains unclear. This study aimed to elucidate how USP39 drives immunosuppression and assess its therapeutic potential in HCC. In this study, USP39 expression and prognostic relevance were analyzed using public databases and clinical samples. Functional assays were performed in vitro and in vivo. Mechanistic studies, including Co-IP/MS and GST pull-down, identified LDHA as a direct target deubiquitinated by USP39 at K318. Glycolytic activity, lactate secretion, and PD-L1 expression were assessed. A syngeneic mouse model evaluated the combined effect of USP39 knockdown and anti–PD-L1 therapy. The results indicated that USP39 was overexpressed in HCC and correlated with poor prognosis. It stabilized LDHA via deubiquitination, enhancing glycolysis and lactate production. Lactate acidified the TME, induced PD-L1 upregulation, and led to CD8⁺T cell exhaustion. USP39 depletion synergized strongly with anti–PD-L1 treatment, suppressing tumor growth and restoring T cell function. Overall, USP39 promotes ICI resistance by stabilizing LDHA to enhance glycolytic metabolism and foster an immunosuppressive TME via lactate acidosis and PD-L1 induction. Targeting USP39 may overcome ICI resistance in HCC.

Authors

Institutions

Publication Details

Journal
npj Precision Oncology
Published
2026-11-15
DOI
https://doi.org/10.1038/s41698-026-01803-5
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors

Mengsen Li, Bo Lin, Xueqin Wu, Yuli Zhou et al.
npj Precision Oncology
Cancer Immunotherapy and Biomarkers
article

LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors

Mengsen Li, Bo Lin, Xueqin Wu, Yuli Zhou, Luying Zhang, Junnv Xu, Mingyue Zhu, Fang Wang, Kun Liu, Siren Feng
article en

Abstract

Immune checkpoint inhibitors (ICIs) show limited efficacy in hepatocellular carcinoma (HCC) owing to an immunosuppressive tumor microenvironment (TME). Although ubiquitin-specific peptidase 39 (USP39) promotes tumor progression, its role in mediating ICI resistance remains unclear. This study aimed to elucidate how USP39 drives immunosuppression and assess its therapeutic potential in HCC. In this study, USP39 expression and prognostic relevance were analyzed using public databases and clinical samples. Functional assays were performed in vitro and in vivo. Mechanistic studies, including Co-IP/MS and GST pull-down, identified LDHA as a direct target deubiquitinated by USP39 at K318. Glycolytic activity, lactate secretion, and PD-L1 expression were assessed. A syngeneic mouse model evaluated the combined effect of USP39 knockdown and anti–PD-L1 therapy. The results indicated that USP39 was overexpressed in HCC and correlated with poor prognosis. It stabilized LDHA via deubiquitination, enhancing glycolysis and lactate production. Lactate acidified the TME, induced PD-L1 upregulation, and led to CD8⁺T cell exhaustion. USP39 depletion synergized strongly with anti–PD-L1 treatment, suppressing tumor growth and restoring T cell function. Overall, USP39 promotes ICI resistance by stabilizing LDHA to enhance glycolytic metabolism and foster an immunosuppressive TME via lactate acidosis and PD-L1 induction. Targeting USP39 may overcome ICI resistance in HCC.

npj Precision Oncology
Hainan Medical University (CN)
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon